Based on the Editas Medicine Inc stock forecast from 1 analysts, the average analyst target price for Editas Medicine Inc is USD 20.00 over the next 12 months. Editas Medicine Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Editas Medicine Inc is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, Editas Medicine Inc’s stock price was USD 5.67. Editas Medicine Inc’s stock price has changed by +6.58% over the past week, -17.35% over the past month and -32.18% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for EDIT !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
